March 2, 2021, 4:10 a.m. EST

Generic Injectables Market: Global Size, Share, PDF Report, Trends and Forecast to 2021-26

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

Mar 02, 2021 (SUPER MARKET RESEARCH via COMTEX) --

The latest report by IMARC Group, titled "Generic Injectables Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026," finds that the global generic injectables market is witnessing moderate growth . Generic injectables consist of the same active ingredients as that of their branded counterparts. They also offer similar active therapeutic effects, strength, quality, performance, intended usage, and dosage. Injectables help in the easy transportation of drugs directly into the body in liquid form, which reduces the frequency of dosage administration without affecting the effectiveness of the treatment. They also do not require extensive investments, resulting in limited price erosion and significantly high-profit margins for manufacturers.

Request Free Sample Report: https://www.imarcgroup.com/generic-injectables-market/requestsample

Global Generic Injectables Market Trends:

The global generic injectables market is primarily driven by their growing preference over oral counterparts as they are preferred by patients who are unable to take medicines by mouth and have poor intestinal absorption. Apart from this, governments across various countries are supporting the manufacturing of generic injectables to reduce the overall cost for healthcare providers and patients. Besides this, the increasing prevalence of chronic diseases like diabetes, cardiovascular disorders, and Alzheimer's, especially among the geriatric population, and the rising shortage of drugs are significantly contributing to the market growth. Furthermore, several key players are engaging in acquisitions and focusing on research and development (R&D) activities to develop complex and differentiated products. For instance, Agila Injectables have been acquired by Mylan Inc. from Strides Arcolab Limited to expand their existing product portfolio. On account of these factors, the market value is expected to reach US$ 445.3 Billion by 2026, exhibiting a CAGR of 7.11% during the forecast period (2021-2026).

Market Summary:

  • Based on the therapeutic area, the market has been segmented into oncology, anesthesia, anti-infectives, parenteral nutrition and cardiovascular. Oncology currently represents the largest therapeutic area, accounting for the majority of the global market share.

  • On the basis of the container, vials are the most preferred container for generic injectables, followed by ampoules, premix and prefilled syringes.

  • The market has been categorized based on the distribution channel into hospitals and retail pharmacies. At present, generic injectables are majorly distributed through hospitals.

  • Region-wise, North America holds the leading position in the market. Other major regions include Asia Pacific, Europe, Middle East and Africa, and Latin America.

  • The competitive landscape of the market has been examined, with some of the key players being Pfizer Inc. (Hospira, Inc.), Fresenius Kabi AG, Hikma Pharmaceuticals PLC, Sandoz (Novartis), Sagent M&C, LLC, Sanofi S.A. and Baxter International, Inc.

Ask Analyst and Download Full Report with TOC & List of Figure: http://bit.ly/2xC7cKe

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Contact Us

IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

The post Generic Injectables Market: Global Size, Share, PDF Report, Trends and Forecast to 2021-26 appeared first on Super Market Research .

COMTEX_381982130/2607/2021-03-02T04:09:58

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.